Author:
Colbert Robert A.,Cronstein Bruce N.
Funder
NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases Intramural Research Program)
NIH
New York University-New York City Health and Hospitals Corporation (NYU-HHC) Clinical and Translational Science Institute, which receives NIH funding
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference6 articles.
1. Biosimilars encircle Rituxan, US debates innovator exclusivity;Carey;Nat Biotech,2011
2. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000;Haas;Ann Intern Med,2005
3. Biosimilar epoetins and other “follow-on” biologics: update on the European experiences;Jelkmann;Am J Hematol,2010
4. Approval pathway for biosimilar and interchangeable biological products; public hearing; request for comments;US Department of Health and Human Services, Food and Drug Administration;Federal Register,2010
5. Hearing shines spotlight on biosimilar controversies;Mullard;Nat Rev Drug Disc,2010
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献